Literature DB >> 9619829

XPA-deficiency in hairless mice causes a shift in skin tumor types and mutational target genes after exposure to low doses of U.V.B.

A de Vries1, R J Berg, S Wijnhoven, A Westerman, P W Wester, C F van Kreijl, P J Capel, F R de Gruijl, H J van Kranen, H van Steeg.   

Abstract

Xeroderma pigmentosum (XP) patients with a defect in the nucleotide excision repair gene XPA, develop tumors with a high frequency on sun-exposed areas of the skin. Here we describe that hairless XPA-deficient mice also develop skin tumors with a short latency time and a 100% prevalence after daily exposure to low doses of U.V.B. Surprisingly and in contrast to U.V.B.-exposed repair proficient hairless mice who mainly develop squamous cell carcinomas, the XPA-deficient mice developed papillomas with a high frequency (31%) at a U.V. dose of 32 J/m2 daily. At the highest daily dose of 80 J/m2 mainly squamous cell carcinomas (56%) and only 10% of papillomas were found in XPA-deficient hairless mice. p53 gene mutations were examined in exons 5, 7 and 8 and were detected in only 3 out of 37 of these skin tumors, whereas in tumors of control U.V.B.-irradiated wild type littermates this frequency was higher (45%) and more in line with our previous data. Strikingly, a high incidence of activating ras gene mutations were observed in U.V.B.-induced papillomas (in 11 out of 14 tumors analysed). In only two out of 14 squamous cell carcinomas we found similar ras gene mutations. The observed shift from squamous cell carcinomas in wild type hairless mice to papillomas in XPA-deficient hairless mice, and a corresponding shift in mutated cancer genes in these tumors, provide new clues on the pathogenesis of chemically- versus U.V.B.-induced skin carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9619829     DOI: 10.1038/sj.onc.1201744

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  6 in total

Review 1.  Strategies for manipulating the p53 pathway in the treatment of human cancer.

Authors:  T R Hupp; D P Lane; K L Ball
Journal:  Biochem J       Date:  2000-11-15       Impact factor: 3.857

2.  Control of skin cancer by the circadian rhythm.

Authors:  Shobhan Gaddameedhi; Christopher P Selby; William K Kaufmann; Robert C Smart; Aziz Sancar
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-24       Impact factor: 11.205

3.  Age-associated decreases in human DNA repair capacity: Implications for the skin.

Authors:  I M Hadshiew; M S Eller; B A Gilchrest
Journal:  Age (Omaha)       Date:  1999-04

4.  Extrafollicular dermal melanocyte stem cells and melanoma.

Authors:  James D Hoerter; Patrick Bradley; Alexandria Casillas; Danielle Chambers; Carli Denholm; Kimberly Johnson; Brandon Weiswasser
Journal:  Stem Cells Int       Date:  2012-05-10       Impact factor: 5.443

5.  A range finding protocol to support design for transcriptomics experimentation: examples of in-vitro and in-vivo murine UV exposure.

Authors:  Oskar Bruning; Wendy Rodenburg; Conny T van Oostrom; Martijs J Jonker; Mark de Jong; Rob J Dekker; Han Rauwerda; Wim A Ensink; Annemieke de Vries; Timo M Breit
Journal:  PLoS One       Date:  2014-05-13       Impact factor: 3.240

Review 6.  Pathogenesis of Skin Carcinomas and a Stem Cell as Focal Origin.

Authors:  Frank R de Gruijl; Cornelis P Tensen
Journal:  Front Med (Lausanne)       Date:  2018-05-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.